Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case

Gynecol Oncol. 1998 Aug;70(2):289-94. doi: 10.1006/gyno.1998.5046.

Abstract

Objective: We report an occult primary papillary serous carcinoma of the endocervix that was encountered in a woman whose mother and identical twin sister died of papillary serous carcinomas (PSCs) of the peritoneum and ovary, respectively.

Methods: The medical records and the histologic material belonging to the patient, her sister, and her mother were reviewed.

Results: The cervical PSC was histologically similar to the peritoneal and ovarian carcinomas. The patient has recurred with peritoneal carcinomatosis 24 months following surgery and postoperative radiotherapy and chemotherapy.

Conclusions: Primary papillary serous carcinoma of the cervix is a very rare adenocarcinoma variant; there have been approximately 30 such cases reported, and, to our knowledge, this is the first documented case of familial peritoneal/ovarian/uterine papillary serous carcinoma. The prophylaxis achieved through bilateral oophorectomy in individuals with a family history of ovarian cancer does not address the risk of PSCs arising in the uterus, cervix, or peritoneum.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cystadenocarcinoma, Papillary / drug therapy
  • Cystadenocarcinoma, Papillary / genetics
  • Cystadenocarcinoma, Papillary / pathology*
  • Family*
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Multiple Primary / drug therapy
  • Neoplasms, Multiple Primary / genetics
  • Neoplasms, Multiple Primary / pathology*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / pathology*
  • Pedigree
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / genetics
  • Peritoneal Neoplasms / pathology*
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / genetics
  • Uterine Cervical Neoplasms / pathology*